Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer

Dearnaley, 2016, Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial, Lancet Oncol, 17, 1047, 10.1016/S1470-2045(16)30102-4 Mayles, 2004, Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397), Radiother Oncol, 73, 199, 10.1016/j.radonc.2004.08.017 Clark, 2009, Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer, Br J Radiol, 82, 585, 10.1259/bjr/31966505 Diaz, 1994, Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, 30, 323, 10.1016/0360-3016(94)90011-6 International Commission on Radiation Units and Measurements, 1999 South, 2008, A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer, Clin Oncol, 20, 15, 10.1016/j.clon.2007.10.012 International Commission on Radiation Units and Measurements, 2010 Low, 1998, A technique for the quantitative evaluation of dose distributions, Med Phys, 25, 656, 10.1118/1.598248 James, 2008 Budgell, 2005, Quantitative analysis of patient-specific dosimetric IMRT verification, Phys Med Biol, 50, 103, 10.1088/0031-9155/50/1/009 Roué, 2004, The EQUAL-ESTRO external quality control laboratory, Cancer Radiother, 8, S44 Alvarez, 2017, TLD and OSLD dosimetry systems for remote audits of radiotherapy external beam calibration, Radiat Meas, 106, 412, 10.1016/j.radmeas.2017.01.005 O'Doherty, 2006, Variability of bladder filling in patients receiving radical radiotherapy to the prostate, Radiother Oncol, 79, 335, 10.1016/j.radonc.2006.05.007 Khoo, 2001, Evaluation of the optimal co-planar field arrangement for use in the boost phase of dose escalated conformal radiotherapy for localized prostate cancer, Br J Radiol, 74, 177, 10.1259/bjr.74.878.740177 Pooler, 2008, Evaluation of margining algorithms in commercial treatment planning systems, Radiother Oncol, 86, 43, 10.1016/j.radonc.2007.11.006 Wilkins, 2015, Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial, Lancet Oncol, 16, 1605, 10.1016/S1470-2045(15)00280-6 Seddon, 2000, Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial, Radiother Oncol, 56, 73, 10.1016/S0167-8140(00)00191-2 Fenton, 2013, Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure, Radiother Oncol, 107, 346, 10.1016/j.radonc.2013.04.020 Kearvell, 2013, Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial, J Med Imaging Radiat Oncol, 57, 247, 10.1111/1754-9485.12025 Matzinger, 2009, Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review, Radiother Oncol, 90, 285, 10.1016/j.radonc.2008.10.022 Sander, 2014, MRI target delineation may reduce long-term toxicity after prostate radiotherapy, Acta Oncol, 53, 809, 10.3109/0284186X.2013.865077 Mangar, 2006, Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397), Radiother Oncol, 80, 355, 10.1016/j.radonc.2006.07.037 Clark, 2009, Dosimetry audit for a multi-centre IMRT head and neck trial, Radiother Oncol, 93, 102, 10.1016/j.radonc.2009.04.025 Weber, 2014, IMRT credentialing for prospective trials using institutional virtual phantoms: results of a joint European Organization for the Research and Treatment of Cancer and Radiological Physics Center project, Radiat Oncol, 9, 123, 10.1186/1748-717X-9-123 Kry, 2014, Institutional patient-specific IMRT QA does not predict unacceptable plan delivery, Int J Radiat Oncol Biol Phys, 90, 1195, 10.1016/j.ijrobp.2014.08.334 Seravalli, 2018, Auditing local methods for quality assurance in radiotherapy using the same set of predefined treatment plans, Phys Imaging Radiat Oncol, 5, 19, 10.1016/j.phro.2018.01.002 Melidis, 2014, Radiation therapy quality assurance in clinical trials – Global Harmonisation Group, Radiother Oncol, 111, 327, 10.1016/j.radonc.2014.03.023